ToxSci Advance Access originally published online on October 20, 2004
Toxicological Sciences 2005 83(1):44-52; doi:10.1093/toxsci/kfi013
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Toxicological Sciences vol. 83 no. 1 © Society of Toxicology 2005; all rights reserved.
Differential Expression of Mouse Hepatic Transporter Genes in Response to Acetaminophen and Carbon Tetrachloride
* Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut 06269; Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas 66160; and Department of Pharmacology and Toxicology, University of Arizona, Tucson, Arizona 85721
Received October 6, 2004; accepted October 8, 2004
Drug-metabolizing enzymes and membrane transporters are responsible for the detoxication and elimination of xenobiotics from the body. The goal of this study was to identify alterations in mRNA expression of various transport and detoxication proteins in mouse liver after administration of the hepatotoxicants, acetaminophen or carbon tetrachloride. Therefore, male C57BL/6 J mice received acetaminophen (APAP, 200, 300, or 400 mg/kg, ip) or carbon tetrachloride (CCl4, 10 or 25 µl/kg, ip). Plasma and liver samples were collected at 6, 24, and 48 h for assessment of alanine aminotransferase (ALT) activity, total RNA isolation, and histopathological analysis of injury. Heme oxygenase-1 (Ho-1), NAD(P)H quinone oxidoreductase-1 (Nqo1), organic anion-transporting polypeptides (Oatp1a1, 1a4 and 1b2), sodium/taurocholate-cotransporting polypeptide (Ntcp), and multidrug resistance-associated protein (Mrp 1–6) mRNA levels in liver were determined using the branched DNA signal amplification assay. Hepatotoxic doses of APAP and CCl4 increased Ho-1 and Nqo1 mRNA levels by 22- and 2.5-fold, respectively, and reduced Oatp1a1, 1a4, and Ntcp mRNA levels in liver. By contrast, expression of Mrps 1–4 was increased after treatment with APAP and CCl4. Notably, a marked elevation of Mrp4 mRNA expression was observed 24 h after APAP 400 mg/kg (5-fold) and CCl4 25 µl/kg (37-fold). Collectively, these expression patterns suggest a coordinated regulation of both transport and detoxification genes during liver injury. This reduction in expression of uptake transporters, as well as enhanced transcription of detoxication enzymes and export transporters may limit the accumulation of potentially toxic products in hepatocytes.
Key Words: acetaminophen; carbon tetrachloride; hepatotoxicity; transporters; Mrp4.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. J. Cui, L. M. Aleksunes, Y. Tanaka, M. J. Goedken, and C. D. Klaassen Compensatory Induction of Liver Efflux Transporters in Response to ANIT-Induced Liver Injury Is Impaired in FXR-Null Mice Toxicol. Sci., July 1, 2009; 110(1): 47 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Hu, K. E. Sampson, B. R. Heyde, K. M. Mandrell, N. Li, A. Zutshi, and Y. Lai Saturation of Multidrug-Resistant Protein 2 (Mrp2/Abcc2)-Mediated Hepatobiliary Secretion: Nonlinear Pharmacokinetics of a Heterocyclic Compound in Rats after Intravenous Bolus Administration Drug Metab. Dispos., April 1, 2009; 37(4): 841 - 846. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Tanaka, L. M. Aleksunes, Y. J. Cui, and C. D. Klaassen ANIT-Induced Intrahepatic Cholestasis Alters Hepatobiliary Transporter Expression via Nrf2-Dependent and Independent Signaling Toxicol. Sci., April 1, 2009; 108(2): 247 - 257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Maher, L. M. Aleksunes, M. Z. Dieter, Y. Tanaka, J. M. Peters, J. E. Manautou, and C. D. Klaassen Nrf2- and PPAR{alpha}-Mediated Regulation of Hepatic Mrp Transporters after Exposure to Perfluorooctanoic Acid and Perfluorodecanoic Acid Toxicol. Sci., December 1, 2008; 106(2): 319 - 328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Merrell, J. P. Jackson, L. M. Augustine, C. D. Fisher, A. L. Slitt, J. M. Maher, W. Huang, D. D. Moore, Y. Zhang, C. D. Klaassen, et al. The Nrf2 Activator Oltipraz Also Activates the Constitutive Androstane Receptor Drug Metab. Dispos., August 1, 2008; 36(8): 1716 - 1721. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Aleksunes, S. N. Campion, M. J. Goedken, and J. E. Manautou Acquired Resistance to Acetaminophen Hepatotoxicity is Associated with Induction of Multidrug Resistance-Associated Protein 4 (Mrp4) in Proliferating Hepatocytes Toxicol. Sci., August 1, 2008; 104(2): 261 - 273. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. N. Campion, R. Johnson, L. M. Aleksunes, M. J. Goedken, N. van Rooijen, G. L. Scheffer, N. J. Cherrington, and J. E. Manautou Hepatic Mrp4 induction following acetaminophen exposure is dependent on Kupffer cell function Am J Physiol Gastrointest Liver Physiol, August 1, 2008; 295(2): G294 - G304. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. M. Villanueva, M. L. Ruiz, C. I. Ghanem, M. G. Luquita, V. A. Catania, and A. D. Mottino Hepatic Synthesis and Urinary Elimination of Acetaminophen Glucuronide Are Exacerbated in Bile Duct-Ligated Rats Drug Metab. Dispos., March 1, 2008; 36(3): 475 - 480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. D. Beilke, D. G. Besselsen, Q. Cheng, S. Kulkarni, A. L. Slitt, and N. J. Cherrington Minimal Role of Hepatic Transporters in the Hepatoprotection against LCA-Induced Intrahepatic Cholestasis Toxicol. Sci., March 1, 2008; 102(1): 196 - 204. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. N. Barnes, L. M. Aleksunes, L. Augustine, G. L. Scheffer, M. J. Goedken, A. B. Jakowski, I. M. Pruimboom-Brees, N. J. Cherrington, and J. E. Manautou Induction of Hepatobiliary Efflux Transporters in Acetaminophen-Induced Acute Liver Failure Cases Drug Metab. Dispos., October 1, 2007; 35(10): 1963 - 1969. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Aleksunes and J. E. Manautou Emerging Role of Nrf2 in Protecting Against Hepatic and Gastrointestinal Disease Toxicol Pathol, June 1, 2007; 35(4): 459 - 473. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Lickteig, A. L. Slitt, M. C. Arkan, M. Karin, and N. J. Cherrington Differential Regulation of Hepatic Transporters in the Absence of Tumor Necrosis Factor-{alpha}, Interleukin-1{beta}, Interleukin-6, and Nuclear Factor-{kappa}B in Two Models of Cholestasis Drug Metab. Dispos., March 1, 2007; 35(3): 402 - 409. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Tanaka, J. M. Maher, C. Chen, and C. D. Klaassen Hepatic Ischemia-Reperfusion Induces Renal Heme Oxygenase-1 via NF-E2-Related Factor 2 in Rats and Mice Mol. Pharmacol., March 1, 2007; 71(3): 817 - 825. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Sarkadi, L. Homolya, G. Szakacs, and A. Varadi Human Multidrug Resistance ABCB and ABCG Transporters: Participation in a Chemoimmunity Defense System. Physiol Rev, October 1, 2006; 86(4): 1179 - 1236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Dai, L. He, N. Chou, and Y.-J. Y. Wan Acetaminophen Metabolism Does Not Contribute to Gender Difference in Its Hepatotoxicity in Mouse Toxicol. Sci., July 1, 2006; 92(1): 33 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nishiya, H. Kataoka, K. Mori, M. Goto, T. Sugawara, and K. Furuhama Tienilic Acid Enhances Hyperbilirubinemia in Eisai Hyperbilirubinuria Rats through Hepatic Multidrug Resistance-Associated Protein 3 and Heme Oxygenase-1 Induction Toxicol. Sci., June 1, 2006; 91(2): 651 - 659. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Moffit, L. M. Aleksunes, J. M. Maher, G. L. Scheffer, C. D. Klaassen, and J. E. Manautou Induction of Hepatic Transporters Multidrug Resistance-Associated Proteins (Mrp) 3 and 4 by Clofibrate Is Regulated by Peroxisome Proliferator-Activated Receptor {alpha} J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 537 - 545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Slitt, N. J. Cherrington, M. Z. Dieter, L. M. Aleksunes, G. L. Scheffer, W. Huang, D. D. Moore, and C. D. Klaassen trans-Stilbene Oxide Induces Expression of Genes Involved in Metabolism and Transport in Mouse Liver via CAR and Nrf2 Transcription Factors Mol. Pharmacol., May 1, 2006; 69(5): 1554 - 1563. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. C. Burcham Molecular Basis for Adaptive Responses during Chemically Induced Hepatotoxicity Toxicol. Sci., February 1, 2006; 89(2): 349 - 351. [Full Text] [PDF]
|
|
|
|
|
|
L. M. Aleksunes, G. L. Scheffer, A. B. Jakowski, I. M. Pruimboom-Brees, and J. E. Manautou Coordinated Expression of Multidrug Resistance-Associated Proteins (Mrps) in Mouse Liver during Toxicant-Induced Injury Toxicol. Sci., February 1, 2006; 89(2): 370 - 379. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. I. Ghanem, M. L. Ruiz, S. S. M. Villanueva, M. G. Luquita, V. A. Catania, B. Jones, L. A. Bengochea, M. Vore, and A. D. Mottino Shift from Biliary to Urinary Elimination of Acetaminophen-Glucuronide in Acetaminophen-Pretreated Rats J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 987 - 995. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Cheng, J. Maher, M. Z. Dieter, and C. D. Klaassen REGULATION OF MOUSE ORGANIC ANION-TRANSPORTING POLYPEPTIDES (OATPS) IN LIVER BY PROTOTYPICAL MICROSOMAL ENZYME INDUCERS THAT ACTIVATE DISTINCT TRANSCRIPTION FACTOR PATHWAYS Drug Metab. Dispos., September 1, 2005; 33(9): 1276 - 1282. [Abstract] [Full Text] [PDF]
|
|